Addressing our key goal to determine the role of αSyn co-pathology in AD-related tau pathophysiology, our first major finding was that Aβ-associated CSF p-tau181 levels were higher in αSyn SAA positive vs. negative individuals. Here, MAPT is linked to Alzheimer disease.